Top compounds associated with response to AC007325.4


Feature Type Standardized
Nominal ANOVA
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.005
mRNA canertinib CTRPv2 pan-cancer AAC 0.1 0.005
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.1 0.006
mRNA A-804598 CTRPv2 pan-cancer AAC 0.12 0.007
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.008
mRNA parbendazole CTRPv2 pan-cancer AAC -0.082 0.008
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.096 0.008
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.11 0.008
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.074 0.009
mRNA CIL56 CTRPv2 pan-cancer AAC -0.12 0.009
Download CSV